Table 2.

Unsolicited cutaneous adverse reactions reported in Moderna phase 3 trial.

Adverse reaction (unsolicited)	Moderna vaccine (N = 15,185), n (%)	Placebo (N = 15,166), n (%)
Dermatitis contact	21 (0.1)	29 (0.2)
Exfoliative rash	1 (<0.1)	0 (0)
Hand dermatitis	2 (<0.1)	0 (0)
Injection site rash	37 (0.2)	1 (<0.1)
Injection site urticarial	15 (<0.1)	0 (0)
Maculopapular rash	11 (<0.1)	2 (<0.1)
Vesicular rash	3 (<0.1)	0 (0)
Facial swelling	4 (<0.1)	2 (<0.1)
Urticaria	27 (0.2)	23 (0.2)

Source: Baden et al., 2020.